Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-02-21 @ 10:15 PM
Study NCT ID:
NCT02987205
Status:
COMPLETED
Last Update Posted:
2018-02-22
First Post:
2016-12-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Multicenter Double-Blind Randomized Split-Face Study to Evaluate Revanesse® Ultra vs Restylane® for Correction of NLF
Sponsor:
Prollenium Medical Technologies Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-05
Start Date Type:
None
Primary Completion Date:
2016-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-05
First Submit QC Date:
None
Study First Post Date:
2016-12-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-08-25
Results First Submit QC Date:
None
Results First Post Date:
2017-12-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-24
Last Update Post Date:
2018-02-22
Last Update Post Date Type:
ACTUAL